NCT04867369View on ClinicalTrials.gov

Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis

PHASE4CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

November 8, 2023

Study Completion Date

November 11, 2023

Conditions
Tendonitis
Interventions
DRUG

Bupivacaine 20mL 0.5%

Interscalene nerve block with 20 mL 0.5% bupivacaine.

DRUG

Bupivacaine 20mL 0.25%

Pecs II fascial plane block with 20 mL 0.25% bupivacaine.

DRUG

Bupivacaine up to 15mL 0.25%

Local infiltration of 0.25% bupivacaine by the surgeon, up to 15 mL.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER